Wirusowe zapalenie wątroby typu C (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Wirusowe zapalenie wątroby typu C" in Polish language version.

refsWebsite
Global rank Polish rank
4th place
7th place
2nd place
6th place
838th place
880th place
1st place
1st place
218th place
561st place
low place
low place
1,916th place
4,399th place
4,581st place
low place
low place
low place
low place
low place
low place
low place
low place
low place
17th place
978th place
low place
low place
low place
6,287th place
195th place
256th place
low place
low place
2,318th place
3,859th place
301st place
151st place

aafp.org

annalsgastro.gr

cdc.gov

  • Hepatitis C. [w:] Center for Disease Control and Prevention [on-line]. [dostęp 2012-01-02].
  • Hepatitis C. [w:] FAQ – CDC Viral Hepatitis [on-line]. [dostęp 2012-01-02].

doi.org

doi.org

  • M. Houghton. The long and winding road leading to the identification of the hepatitis C virus. „Journal of Hepatology”. 51 (5), s. 939–948, listopad 2009. DOI: 10.1016/j.jhep.2009.08.004. PMID: 19781804. 
  • A Maheshwari, S. Ray, Thuluvath, PJ. Acute hepatitis C. „Lancet”. 372 (9635), s. 321–332, 2008-07-26. DOI: 10.1016/S0140-6736(08)61116-2. PMID: 18657711. 
  • HR Rosen. Clinical practice. Chronic hepatitis C infection. „The New England Journal of Medicine”. 364 (25), s. 2429–2438, 2011-06-23. DOI: 10.1056/NEJMcp1006613. PMID: 21696309. 
  • Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. „Digestive and Liver Disease”. 39 (1), s. 2–17, styczeń 2007. DOI: 10.1016/j.dld.2006.06.008. PMID: 16884964. 
  • Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. „Liver Int.”, grudzień 2011. DOI: 10.1111/j.1478-3231.2011.02684.x. PMID: 22142261. 
  • X Xia, J. Luo, J. Bai, R. Yu. Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis. „Public health”. 122 (10), s. 990–1003, październik 2008. DOI: 10.1016/j.puhe.2008.01.014. PMID: 18486955. 
  • Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission?. „Hepatology”. 52 (4), s. 1497–1505, czerwiec 2010. DOI: 10.1002/hep.23808. PMID: 20635398. 
  • Lock G, Dirscherl M, Obermeier F, et al.. Hepatitis C –contamination of toothbrushes: myth or reality?. „J. Viral Hepat.”. 13 (9), s. 571–573, wrzesień 2006. DOI: 10.1111/j.1365-2893.2006.00735.x. PMID: 16907842. 
  • J Halliday, P. Klenerman, E. Barnes. Vaccination for hepatitis C virus: closing in on an evasive target. „Expert review of vaccines”. 10 (5), s. 659–672, maj 2011. DOI: 10.1586/erv.11.55. PMID: 21604986. 
  • J Torresi, D. Johnson, H. Wedemeyer. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. „Journal of hepatology”. 54 (6), s. 1273–1285, czerwiec 2011. DOI: 10.1016/j.jhep.2010.09.040. PMID: 21236312. 
  • Foote BS, Spooner LM, Belliveau PP. Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C. „Ann Pharmacother”. 45 (9), s. 1085–1093, wrzesień 2011. DOI: 10.1345/aph.1P744. PMID: 21828346. 
  • Smith LS, Nelson M, Naik S, Woten J. Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C. „Ann Pharmacother”. 45 (5), s. 639–648, maj 2011. DOI: 10.1345/aph.1P430. PMID: 21558488. 
  • Ghany MG, Nelson DR, Strader DB, Thomas DL i inni. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. „Hepatology”. 54 (4), s. 1433–1444, październik 2011. DOI: 10.1002/hep.24641. PMID: 21898493. PMCID: PMC3229841. 
  • Fung J, Lai CL, Hung I, et al.. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. „The Journal of Infectious Diseases”. 198 (6), s. 808–812, wrzesień 2008. DOI: 10.1086/591252. PMID: 18657036. 
  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. „Science”. 244 (4902), s. 359–362, kwiecień 1989. DOI: 10.1126/science.2523562. PMID: 2523562. 
  • Kuo G, Choo QL, Alter HJ, et al.. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. „Science”. 244 (4902), s. 362–364, kwiecień 1989. DOI: 10.1126/science.2496467. PMID: 2496467. 
  • A.C. El Khoury, W.K. Klimack, C. Wallace, H. Razavi. Economic burden of hepatitis C-associated diseases in the United States. „Journal of Viral Hepatitis”, 2011-12-01. DOI: 10.1111/j.1365-2893.2011.01563.x. 
  • J Ahn, SL Flamm. Hepatitis C therapy: other players in the game. „Clinics in liver disease”. 15 (3), s. 641–656, sierpień 2011. DOI: 10.1016/j.cld.2011.05.008. PMID: 21867942. 

dx.doi.org

georgetown.edu

ll.georgetown.edu

google.ca

books.google.ca

hcvguidelines.org

indiatimes.com

timesofindia.indiatimes.com

infohep.org

laskerfoundation.org

natap.org

nih.gov

ncbi.nlm.nih.gov

  • M. Houghton. The long and winding road leading to the identification of the hepatitis C virus. „Journal of Hepatology”. 51 (5), s. 939–948, listopad 2009. DOI: 10.1016/j.jhep.2009.08.004. PMID: 19781804. 
  • A Maheshwari, S. Ray, Thuluvath, PJ. Acute hepatitis C. „Lancet”. 372 (9635), s. 321–332, 2008-07-26. DOI: 10.1016/S0140-6736(08)61116-2. PMID: 18657711. 
  • T Wilkins, Malcolm, JK, D. Raina, Schade, RR. Hepatitis C: diagnosis and treatment. „American family physician”. 81 (11), s. 1351–1357, 2010-06-01. PMID: 20521755. 
  • HR Rosen. Clinical practice. Chronic hepatitis C infection. „The New England Journal of Medicine”. 364 (25), s. 2429–2438, 2011-06-23. DOI: 10.1056/NEJMcp1006613. PMID: 21696309. 
  • S Mueller, G Millonig, HK Seitz. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. „World journal of gastroenterology: WJG”. 15 (28), s. 3462–3471, 2009-07-28. PMID: 19630099. 
  • MJ Alter. Epidemiology of hepatitis C virus infection. „World journal of gastroenterology: WJG”. 13 (17), s. 2436–2441, 2007-05-07. PMID: 17552026. 
  • R Ozaras, V. Tahan. Acute hepatitis C: prevention and treatment. „Expert review of anti-infective therapy”. 7 (3), s. 351–361, kwiecień 2009. PMID: 19344247. 
  • Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. „Digestive and Liver Disease”. 39 (1), s. 2–17, styczeń 2007. DOI: 10.1016/j.dld.2006.06.008. PMID: 16884964. 
  • KS Louie, Micallef, JM, Pimenta, JM, Forssen, UM. Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review. „Journal of viral hepatitis”. 18 (1), s. 1–7, styczeń 2011. PMID: 20796208. 
  • Nakano T, Lau GM, Lau GM, Sugiyama M, Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. „Liver Int.”, grudzień 2011. DOI: 10.1111/j.1478-3231.2011.02684.x. PMID: 22142261. 
  • A Maheshwari, Thuluvath, PJ. Management of acute hepatitis C. „Clinics in liver disease”. 14 (1), s. 169–176, luty 2010. PMID: 20123448. 
  • RA Pondé, A. Mikhaĭlova. Hidden hazards of HCV transmission. „Medical microbiology and immunology”. 200 (1), s. 7–11, luty 2011. PMID: 20461405. 
  • X Xia, J. Luo, J. Bai, R. Yu. Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis. „Public health”. 122 (10), s. 990–1003, październik 2008. DOI: 10.1016/j.puhe.2008.01.014. PMID: 18486955. 
  • Paul K Nelson i inni, Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews, „The Lancet”, 378 (9791), 2011, s. 571–83, DOI10.1016/S0140-6736(11)61097-0, PMID21802134, PMCIDPMC3285467.
  • JC Imperial. Chronic hepatitis C in the state prison system: insights into the problems and possible solutions. „Expert review of gastroenterology & hepatology”. 4 (3), s. 355–364, czerwiec 2010. PMID: 20528122. 
  • M F Vescio i inni, Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis, „Journal of epidemiology and community health”, 62 (4), 2008, s. 305–13, DOI10.1136/jech.2006.051599, PMID18339822.
  • Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission?. „Hepatology”. 52 (4), s. 1497–1505, czerwiec 2010. DOI: 10.1002/hep.23808. PMID: 20635398. 
  • S Jafari, R. Copes, S. Baharlou, M. Etminan i inni. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. „International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases”. 14 (11), s. e928-40, listopad 2010. PMID: 20678951. 
  • Lock G, Dirscherl M, Obermeier F, et al.. Hepatitis C –contamination of toothbrushes: myth or reality?. „J. Viral Hepat.”. 13 (9), s. 571–573, wrzesień 2006. DOI: 10.1111/j.1365-2893.2006.00735.x. PMID: 16907842. 
  • NC Lam, PB Gotsch, RC Langan. Caring for pregnant women and newborns with hepatitis B or C. „American family physician”. 82 (10), s. 1225–1229, 2010-11-15. PMID: 21121533. 
  • Mast EE. Mother-to-infant hepatitis C virus transmission and breastfeeding. „Advances in Experimental Medicine and Biology”. 554, s. 211–216, 2004. PMID: 15384578. 
  • V Senadhi. A paradigm shift in the outpatient approach to liver function tests. „Southern medical journal”. 104 (7), s. 521–525, lipiec 2011. PMID: 21886053. 
  • J Halliday, P. Klenerman, E. Barnes. Vaccination for hepatitis C virus: closing in on an evasive target. „Expert review of vaccines”. 10 (5), s. 659–672, maj 2011. DOI: 10.1586/erv.11.55. PMID: 21604986. 
  • H Hagan, Pouget, ER, Des Jarlais, DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. „The Journal of infectious diseases”. 204 (1), s. 74–83, 2011-07-01. PMID: 21628661. 
  • J Torresi, D. Johnson, H. Wedemeyer. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. „Journal of hepatology”. 54 (6), s. 1273–1285, czerwiec 2011. DOI: 10.1016/j.jhep.2010.09.040. PMID: 21236312. 
  • JA Ilyas, JM Vierling. An overview of emerging therapies for the treatment of chronic hepatitis C. „Clinics in liver disease”. 15 (3), s. 515–536, sierpień 2011. PMID: 21867934. 
  • F.A.C. Berden, W Kievit, L.C. Baak. Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. „The Netherland Journal of Medicine”. 72 (8), s. 388–400, 2014-10. PMID: 25387551. [dostęp 2016-03-05]. (ang.). 
  • E Cholongitas, G.V. Papatheodoridis. Sofosbuvir: a novel oral agent for chronic hepatitis C. „Annals of Gastroenterology”. 27 (4), s. 331–337, 2014. PMID: 25332066. PMCID: PMC4188929. [dostęp 2016-03-05]. (ang.). 
  • T.T. Tran. A Review of Standard and Newer Treatment Strategies in Hepatitis C. „The American Journal of Managed Care”. 18 (14 Suppl), s. 340–349, 2012-12. PMID: 23327540. [dostęp 2016-03-05]. (ang.). 
  • Foote BS, Spooner LM, Belliveau PP. Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C. „Ann Pharmacother”. 45 (9), s. 1085–1093, wrzesień 2011. DOI: 10.1345/aph.1P744. PMID: 21828346. 
  • Smith LS, Nelson M, Naik S, Woten J. Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C. „Ann Pharmacother”. 45 (5), s. 639–648, maj 2011. DOI: 10.1345/aph.1P430. PMID: 21558488. 
  • Ghany MG, Nelson DR, Strader DB, Thomas DL i inni. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. „Hepatology”. 54 (4), s. 1433–1444, październik 2011. DOI: 10.1002/hep.24641. PMID: 21898493. PMCID: PMC3229841. 
  • J Liu, E. Manheimer, K. Tsutani, C. Gluud. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. „The American journal of gastroenterology”. 98 (3), s. 538–544, marzec 2003. PMID: 12650784. 
  • A Rambaldi, BP Jacobs, C. Gluud. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. „Cochrane database of systematic reviews (Online)”, s. CD003620, 2007-10-17. PMID: 17943794. 
  • Fung J, Lai CL, Hung I, et al.. Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin. „The Journal of Infectious Diseases”. 198 (6), s. 808–812, wrzesień 2008. DOI: 10.1086/591252. PMID: 18657036. 
  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. „Science”. 244 (4902), s. 359–362, kwiecień 1989. DOI: 10.1126/science.2523562. PMID: 2523562. 
  • Kuo G, Choo QL, Alter HJ, et al.. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. „Science”. 244 (4902), s. 362–364, kwiecień 1989. DOI: 10.1126/science.2496467. PMID: 2496467. 
  • team Eurosurveillance editorial. World Hepatitis Day 2011. „Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin”. 16 (30), 2011-07-28. PMID: 21813077. 
  • JB Wong. Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies. „PharmacoEconomics”. 24 (7), s. 661–672, 2006. PMID: 16802842. 
  • J Ahn, SL Flamm. Hepatitis C therapy: other players in the game. „Clinics in liver disease”. 15 (3), s. 641–656, sierpień 2011. DOI: 10.1016/j.cld.2011.05.008. PMID: 21867942. 
  • J Vermehren, C. Sarrazin. New HCV therapies on the horizon. „Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases”. 17 (2), s. 122–134, luty 2011. PMID: 21087349. 

njmonline.nl

nobelprize.org

rozbrat.org

uw.edu

hepatitisc.uw.edu

va.gov

hepatitis.va.gov

web.archive.org

who.int